Comment re: Temozolomide preferentially depletes cancer stem cells.
Pallini
Roberto
R
Montano
Nicola
N
Larocca
Luigi M
LM
D018906:Antineoplastic Agents, Alkylating / Q000494:pharmacology*; D001932:Brain Neoplasms / Q000188:drug therapy / Q000473:pathology*; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000494:pharmacology; D005909:Glioblastoma / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D008279:Magnetic Resonance Imaging; D014411:Neoplastic Stem Cells / Q000187:drug effects* / Q000473:pathology; D000077204:Temozolomide
D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide